NLRP3 and inflammatory bowel disease: Also, presented with VEO-IBD, the deficiency of the receptor-interacting protein kinase 1 (RIPK1) gene inhibits NLRP3 inflammasome activation upon lipopolysaccharide stimulation, participating in human colitis [48].